Premium Nahrungsergänzungsmittel | artgerecht

Artemisinin – Mechanism, Uses and Effects

Artemisinin is a natural compound derived from the plant Artemisia annua and is considered one of the most potent antimalarial agents in modern medicine.

Regular tips about health Regular tips about health

Things worth knowing about "Artemisinin"

Artemisinin is a natural compound derived from the plant Artemisia annua and is considered one of the most potent antimalarial agents in modern medicine.

What Is Artemisinin?

Artemisinin is a bioactive natural compound extracted from the plant Artemisia annua, commonly known as sweet wormwood or annual wormwood. It was isolated in the 1970s by Chinese scientist Tu Youyou, who was awarded the Nobel Prize in Physiology or Medicine in 2015 for this discovery. Artemisinin transformed the global treatment of malaria and is listed by the World Health Organization (WHO) as an essential medicine.

Mechanism of Action

Artemisinin acts against the malaria parasite Plasmodium through a unique chemical mechanism. The compound contains an endoperoxide bridge – an oxygen-rich chemical group that becomes activated in the presence of iron within the parasite. This activation generates highly reactive free radicals that damage critical proteins and membranes of the parasite, ultimately killing it.

Selective toxicity toward Plasmodium parasites via iron-dependent activation
Generation of reactive oxygen species (ROS) that destroy the parasite
Rapid reduction of parasite levels in the bloodstream within hours
Effective against all intraerythrocytic (red blood cell) stages of the parasite

Medical Applications

Malaria Treatment

Artemisinin is not used as monotherapy but exclusively in Artemisinin-based Combination Therapies (ACT) to prevent the development of resistance. Common partner drugs include lumefantrine, amodiaquine, and mefloquine. The WHO recommends ACT as the first-line treatment for uncomplicated malaria caused by Plasmodium falciparum.

Other Areas of Research

Current scientific studies are exploring the potential of artemisinin and its derivatives in additional medical fields:

Oncology: Preclinical studies indicate antiproliferative properties against various cancer cell lines, as tumor cells are often iron-rich.
Autoimmune diseases: Artemisinin derivatives are being investigated for immunomodulatory effects in conditions such as systemic lupus erythematosus.
Parasitic infections: Potential efficacy against other parasites such as Toxoplasma and Schistosoma is under investigation.

Key Derivatives

Since artemisinin itself has low oral bioavailability and a short half-life, more stable and potent derivatives have been developed:

Artesunate: Water-soluble derivative, also available for intravenous use; drug of choice for severe malaria
Artemether: Lipophilic derivative for oral use; frequently combined with lumefantrine
Dihydroartemisinin (DHA): The active metabolite of artemisinin, also available as an active ingredient in combination products

Dosage and Usage Notes

The dosage of artemisinin derivatives depends on the specific formulation used, the body weight of the patient, and the severity of the infection. Self-medication without medical supervision is strongly discouraged. ACT treatment typically lasts 3 days, and adherence to the full course is essential to avoid promoting resistance.

Side Effects and Safety

Artemisinin and its derivatives are generally well tolerated when used as directed. Possible side effects include:

Nausea, vomiting, and abdominal discomfort
Dizziness and headache
Cardiac arrhythmias, particularly QT prolongation at high doses or in combination with other cardiac medications
In rare cases: neutropenia (reduction in white blood cell count)
Neurotoxicity at very high doses (mainly observed in animal studies)

During pregnancy, especially in the first trimester, artemisinin-based treatments should only be used after careful benefit-risk assessment. In the second and third trimesters, artesunate is considered acceptable when the benefit outweighs the risk.

Resistance Development

Since the 2000s, cases of artemisinin resistance in Plasmodium falciparum have been documented in parts of Southeast Asia, particularly in the Greater Mekong Subregion. Mutations in the K13 gene of the parasite are associated with delayed parasite clearance. The WHO actively monitors resistance patterns and strongly recommends the consistent use of combination therapies to prevent further spread.

References

World Health Organization (WHO): Guidelines for the Treatment of Malaria, 3rd edition, Geneva 2015. Available at: https://www.who.int/publications/i/item/9789241549127
Tu Y.: Artemisinin – A Gift from Traditional Chinese Medicine to the World (Nobel Lecture). Angewandte Chemie International Edition, 2016;55(35):10210–10226. DOI: 10.1002/anie.201601967
Klayman DL.: Qinghaosu (Artemisinin): An Antimalarial Drug from China. Science, 1985;228(4703):1049–1055. DOI: 10.1126/science.3887571

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.